Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02805712 · ClinicalTrials.gov registry record · NA

Focused Palliative Care Intervention in Advanced Heart Failure

A NA study of Heart Failure and Quality of Life, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02805712: Completed NA study of Heart Failure and Quality of Life, sponsored by Brigham and Women's Hospital.

NCT02805712 is a NA study of Heart Failure and Quality of Life that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 50 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02805712, a NA study of Heart Failure and Quality of Life, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on documentation of advanced care planning and end of life preferences, symptom burden, quality of life and health care utilization.

Primary Outcome

Assessment tool: Patient Preferences Questionnaire.

Interventions

  • OTHER Control
  • OTHER Verbal Information and Discussion

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-09
Est. Completion 2016-12-01
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT02805712 record still lists

NCT02805712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT02805712 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02805712 about?

NCT02805712 is a clinical study titled "Focused Palliative Care Intervention in Advanced Heart Failure". This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on docume...

What is the current status of trial NCT02805712?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-09. Estimated completion is 2016-12-01.

What conditions does trial NCT02805712 study?

This clinical trial studies the following conditions: Heart Failure, Quality of Life.

What interventions are being tested in trial NCT02805712?

The interventions under investigation include: Control (OTHER), Verbal Information and Discussion (OTHER).

Who is sponsoring clinical trial NCT02805712?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02805712 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02805712's enrollment target sits among peer trials

50 281st of 397 higher than 106 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02805712, the US trial registry maintained by the National Library of Medicine. NCT02805712 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.